Srinivasan Krishnamoorthy, Sharma Shyam S
Molecular Neuropharmacology Laboratory, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.
Neurol Res. 2011 Oct;33(8):858-65. doi: 10.1179/1743132811Y.0000000015.
Diabetes is one of the major risk factors for ischemic stroke and is reported to aggravate the ischemic brain damage in different experimental models as well as clinical situations. However, the mechanisms underlying the exacerbated ischemia/reperfusion (I/R) brain injury associated with comorbid diabetes are still not clear. This study investigated the role of endoplasmic reticulum (ER) stress in pathophysiology of aggravated I/R brain injury associated with diabetes.
Focal cerebral ischemia was induced by middle cerebral artery occlusion for 2 hours followed by 22 hours of reperfusion in high-fat diet-fed and low-dose streptozotocin-treated type 2 diabetic rats. Immunohistochemistry and western blotting analysis were performed to detect the changes in expression of various ER stress and apoptotic markers such as 78 kDa glucose-regulated protein (GRP78), CCAAT/enhancer binding protein homologous protein or growth arrest DNA damage-inducible gene 153 (CHOP/GADD153), and caspase-12. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay was performed to detect the extent of DNA fragmentation and cell death.
The diabetic rats subjected to I/R manifested significantly larger brain infarct volume and severe deterioration in neurological deficits than their normal, non-diabetic counterparts. There was a marked upregulation of GRP78 observed in brains of diabetic rats after 22 hours of reperfusion. Furthermore, augmentation of CHOP/GADD153 expression and activation of caspase-12 (ER stress-induced apoptotic factors) were observed in parallel with enhanced TUNEL-positive cells or DNA fragmentation in diabetic rats compared to normal rats following cerebral I/R.
Taken together, the current experimental findings demonstrate that diabetes exacerbates brain I/R injury which may be mediated through enhanced ER stress and cell death involving CHOP/GADD153 and caspase-12 activation.
糖尿病是缺血性中风的主要危险因素之一,据报道,在不同的实验模型以及临床情况下,糖尿病会加重缺血性脑损伤。然而,合并糖尿病时缺血再灌注(I/R)脑损伤加剧的潜在机制仍不清楚。本研究探讨内质网(ER)应激在糖尿病相关加重的I/R脑损伤病理生理中的作用。
通过大脑中动脉闭塞2小时,随后在高脂饮食喂养和低剂量链脲佐菌素处理的2型糖尿病大鼠中进行22小时再灌注,诱导局灶性脑缺血。进行免疫组织化学和蛋白质印迹分析,以检测各种ER应激和凋亡标志物的表达变化,如78 kDa葡萄糖调节蛋白(GRP78)、CCAAT/增强子结合蛋白同源蛋白或生长停滞DNA损伤诱导基因153(CHOP/GADD153)以及半胱天冬酶-12。进行末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)分析,以检测DNA片段化程度和细胞死亡情况。
与正常非糖尿病大鼠相比,接受I/R的糖尿病大鼠表现出明显更大的脑梗死体积和神经功能缺损的严重恶化。再灌注22小时后,在糖尿病大鼠的大脑中观察到GRP78明显上调。此外,与正常大鼠相比,糖尿病大鼠在脑I/R后,CHOP/GADD153表达增加和半胱天冬酶-12(ER应激诱导的凋亡因子)激活,同时TUNEL阳性细胞或DNA片段化增强。
综上所述,目前的实验结果表明,糖尿病会加重脑I/R损伤,这可能是通过增强ER应激以及涉及CHOP/GADD153和半胱天冬酶-12激活的细胞死亡介导的。